Structure of Arbutin
CAS No.: 497-76-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Arbutin is an inhibitor of tyrosinase with IC50 of 1.09 mM and can prevent the formation of melanin. It is a glycosylated hydroquinone found in the leaves of arctostaphylos uvaursi.
Synonyms: β-Arbutin; NSC 4036; Uvasol
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 497-76-7 |
| Formula : | C12H16O7 |
| M.W : | 272.25 |
| SMILES Code : | OC1=CC=C(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1 |
| Synonyms : |
β-Arbutin; NSC 4036; Uvasol
|
| MDL No. : | MFCD00016915 |
| InChI Key : | BJRNKVDFDLYUGJ-RMPHRYRLSA-N |
| Pubchem ID : | 440936 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
| Target |
|
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| IEC-6 cells | 500 µM | 12 hours | To evaluate the effect of Arbutin on LPS-induced apoptosis in IEC-6 cells, results showed that Arbutin significantly inhibited LPS-induced apoptosis. | Front Pharmacol. 2021 Sep 14;12:683818. |
| 3T3-L1 cells | 75 µM | 24 hours | Arbutin reduced intracellular TG levels in 3T3-L1 cells without affecting cell viability. | Redox Biol. 2023 Dec;68:102963. |
| HepG2 cells | 75 µM | 24 hours | Arbutin reduced intracellular lipid deposition in HepG2 cells, decreased intracellular TG and TC levels, and reduced lipid droplet accumulation. Additionally, Arbutin inhibited the expression of lipid synthesis genes and promoted the expression of genes involved in lipid catabolism and transport. | Redox Biol. 2023 Dec;68:102963. |
| L-02 cells | 25, 50, 100, 200 µM | 24 hours | To evaluate the cytotoxicity of arbutin on hepatocytes, results showed that arbutin at concentrations of 0–200μM for 24 hours had no significant proliferative inhibition on L-02 cells. | Front Cell Dev Biol. 2021 Dec 2;9:758632. |
| IEC-6 cells | 10-800 µM | 24 hours | To evaluate the effect of Arbutin on cell viability, results showed that Arbutin had no significant effect on IEC-6 cell viability at concentrations ranging from 10-800 μM. | Front Pharmacol. 2021 Sep 14;12:683818. |
| PDPCs cells | 0.2 mM | 72 hours | Evaluate the protective effect of Arbutin on PDPCs cells under oxidative stress, results showed Arbutin restored cell viability and promoted the expression of differentiation markers | Antioxidants (Basel). 2020 Jul 2;9(7):579. |
| Saos-2 cells | 0.2 mM | 72 hours | Evaluate the protective effect of Arbutin on Saos-2 cells under oxidative stress, results showed Arbutin restored cell viability | Antioxidants (Basel). 2020 Jul 2;9(7):579. |
| C57BL/6 mice chondrocytes | 0.5 mg/mL | GM-Lipo@ARB effectively reduced the inflammatory response in IL-1β-treated arthritic chondrocytes and regulated cartilage ECM homeostasis by inhibiting NF-κB signaling and activating the Nrf2 pathway. | Mater Today Bio. 2022 Jul 19;16:100370. |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| C57BL/6 mice | Normal mice and antibiotic-treated mice | Oral | 0.1, 0.2, 0.4, 1 mg/ml | 3 weeks | To investigate the effects of Arbutin on gut development and serum lipids, results showed that Arbutin promoted gut development (e.g., villus length, villus areas) and reduced serum lipids (e.g., total cholesterol, high-density lipoprotein). | Front Nutr. 2022 Sep 9;9:948573 |
| C57BL/6 mice | High-fat diet-induced obesity model | Oral | 1 g/kg | Continued for 10 weeks | Arbutin significantly alleviated high-fat diet-induced obesity and hepatic lipid deposition in mice, reduced liver TG and TC levels, and improved glucose metabolism and insulin sensitivity. Additionally, Arbutin reduced oxidative stress and iron overload, and inhibited ferroptosis. | Redox Biol. 2023 Dec;68:102963. |
| C57BL/6 mice | ANIT-induced cholestatic liver injury model | Intraperitoneal injection | 10, 20, 40 mg/kg | Once daily for one week | To evaluate the protective effect of arbutin on ANIT-induced cholestatic liver injury, results showed that arbutin significantly reduced serum levels of ALT, AST, TBIL, γ-GT, TBA, and ALP, and improved liver pathological changes. | Front Cell Dev Biol. 2021 Dec 2;9:758632. |
| Lewis rats | Lewis rats | Oral | 200 mg/kg | Daily administration for 14 or 28 days | To evaluate the effects of strawberry tree water leaf extract (STE) and arbutin on biochemical markers and DNA integrity in the brain tissue of Lewis rats. Results indicated high biocompatibility of both substances with rat brain tissue, with no significant harmful disturbances in oxidative/antioxidative status or DNA integrity. | Toxics. 2024 Aug 16;12(8):595 |
| C57BL/6 mice | Destabilization of the medial meniscus (DMM)-induced osteoarthritis model | Intra-articular injection | 25 mg/kg | Once every two weeks for eight weeks | Intra-articular use of GM-Lipo@ARB can effectively reduce inflammation and oxidative stress in the articular cartilage and thus, attenuating OA progression in a Mice model. | Mater Today Bio. 2022 Jul 19;16:100370. |
| Rats | Lead acetate-induced testicular injury model | Oral | 250 mg/kg | Once daily for 10 days | Arbutin ameliorates Pb-evoked testicular damage by stimulating testicular antioxidants and the PK2/PKR2 pathway and inhibiting the JAK2/STAT3 and NLRP3/caspase-1 pro-inflammatory pathways. Intraperitoneal arbutin at a lower dose prompted a more pronounced mitigation of Pb-induced testicular dysfunction compared to oral administration. | Pharmaceuticals (Basel). 2024 Jul 8;17(7):909 |
| C57BL/6 mice | DSS-induced colitis model | Gavage | 50 and 100 mg/kg | Once daily for 7 consecutive days | To evaluate the effect of Arbutin on DSS-induced colitis symptoms, results showed that Arbutin significantly alleviated colitis symptoms, including body weight loss, increased disease activity index, and increased colon weight/length ratio. | Front Pharmacol. 2021 Sep 14;12:683818. |
| Swiss albino mice | MPTP-induced Parkinson’s disease model | Intraperitoneal injection | 50 and 100 mg/kg | Once daily for 7 days | Arbutin significantly reduced lipid peroxidation, total nitrite levels, and inflammation in the substantia nigra and striatum of PD Mice models. In addition, arbutin decreased the activity of endogenous antioxidants, reduced the levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and γ-aminobutyric acid, and minimized neurodegeneration in the striatum. Arbutin also improved the abnormal performance of PD Mice models in the open field test, bar test, pole test, and rotarod test. | Neural Regen Res. 2021 Oct;16(10):2030-2040 |
| BALB/c mice | DSS-induced ulcerative colitis model | Intragastric administration | 50 mg/kg and 100 mg/kg | Once daily for 7 days | Arbutin ameliorated DSS-induced ulcerative colitis by eliciting anti-inflammatory effects and maintaining normal intestinal mucosal barrier function, the action mechanism of which could be associated with MAPK/ELK1 pathway. | Bioengineered. 2021 Dec;12(2):11707-11715 |
| Rats | Lead acetate-induced testicular injury model | Intraperitoneal injection | 75 mg/kg | Once daily for 10 days | Arbutin ameliorates Pb-evoked testicular damage by stimulating testicular antioxidants and the PK2/PKR2 pathway and inhibiting the JAK2/STAT3 and NLRP3/caspase-1 pro-inflammatory pathways. Intraperitoneal arbutin at a lower dose prompted a more pronounced mitigation of Pb-induced testicular dysfunction compared to oral administration. | Pharmaceuticals (Basel). 2024 Jul 8;17(7):909 |
| HRM-2 hairless mice | UV-B-induced skin hyperpigmentation model | Topical application | 0.5% | Twice daily for 25 days | To evaluate the ameliorative effect of BI2B on UV-B-induced skin hyperpigmentation | Int J Biol Sci. 2024 Feb 17;20(5):1688-1704 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT02945891 | Cervical Cancer | Not Applicable | Active, not recruiting | December 2018 | Norway ... More >> Ostfold Hospital Trust Fredrikstad, Norway Oslo University Hospital, Molecular Pathology Oslo, Norway Oslo University Hospital, Ullevål Oslo, Norway Radiumhospital Oslo, Norway Less << |
| NCT00781625 | Urinary Tract Infections | Not Applicable | Unknown | December 2010 | Norway ... More >> Akershus Universitetssykehus HF Recruiting Lørenskog, Akershus, Norway, 1478 Contact: Caroline U Skagemo, MD +47 02900111 cask@ahus.no Contact: Gunn Iren Meling, PhD, MD +47 02900 111 gmel@ahus.no Principal Investigator: Caroline U Skagemo, MD St.Olavs Hospital Active, not recruiting Trondheim, Norway, 7006 Less << |
| NCT02130713 | Chronic Bacterial Prostatitis | Phase 4 | Completed | - | Italy ... More >> policlinico Umberto I - Department of Gynecological-Obstetrics Sciences and Urological Sciences Roma, Italy, 00161 Less << |
| NCT02934724 | - | Active, not recruiting | December 2018 | Norway ... More >> Oslo University Hospital, Cancer Registry of Norway Oslo, Norway, 0379 Less << | |
| NCT01538550 | Colorectal Cancer ... More >> Colorectal Adenomas Less << | Not Applicable | Recruiting | December 2030 | Norway ... More >> Moss Hospital Recruiting Oslo, Norway, 1535 Contact: Anita Jørgensen, RN +4793089107 anita.jorgensen@kreftregisteret.no Contact: Thomas de Lange, MD, PhD +4799030789 t.d.lange@medisin.uio..no Sub-Investigator: Thomas deLange, MD,PhD Principal Investigator: Per Sandvei, MD Bærum County Hospital Enrolling by invitation Rud, Norway, 1309 Less << |
| NCT00717652 | Melasma | Phase 2 Phase 3 | Suspended | - | Brazil ... More >> Lal Clinica Pesquisa E Desenvolvimento Ltda Valinhos, S, Brazil, 13270000 Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.67mL 0.73mL 0.37mL |
18.37mL 3.67mL 1.84mL |
36.73mL 7.35mL 3.67mL |
|
| Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||
Tags: Arbutin | β-Arbutin | Tyrosinase | Endogenous Metabolite | β Arbutin | tyrosinase inhibitor | depigmenting agent | 497-76-7
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


